NASDAQ
Advanced Biomedical Technologies, Inc. (ABMT) has a price/sales ratio of 13.03x as of Friday, May 22, 2026. This represents a 88.96% decrease compared to its 12-month average of 118.00x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.